MedPageToday
MedPage Today) — Although the FDA has expanded approvals for two respiratory syncytial virus (RSV) vaccines to include high-risk young and middle-age adults, CDC advisors have not yet moved to recommend the vaccine in these groups.
In June…
Read More
Should RSV Vaccination Expand to Younger High-Risk Groups?
MedPage Today) — Although the FDA has expanded approvals for two respiratory syncytial virus (RSV) vaccines to include high-risk young and middle-age adults, CDC advisors have not yet moved to recommend the vaccine in these groups. In June…